Prabhjot S. Mundi

Columbia University Irving Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index1.2kcitations125works0.32yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(52), Health Systems, Economic Evaluations, Quality of Life(15), Lung Cancer Treatments and Mutations(10), Bioinformatics and Genomic Networks(10), Neuroendocrine Tumor Research Advances(9)

Publications125 total

Table S5 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Key Resources Table from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S4 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S3 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S7 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S8 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S1 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S2 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Supplementary Figures S1-S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Table S6 from A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

2025Open Access

Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer

1 cited

JAMA Network Open·2025· 1 citedOpen Access

Systematic elucidation and pharmacologic targeting on non-oncogene dependencies in imatinib-resistant gastrointestinal stromal tumor

2025Open Access

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas

3 cited

Journal of Clinical Investigation·2025· 3 citedOpen Access

Abstract P4-01-22: Serum Thymidine Kinase as a Biomarker for Response Beyond Progression in First-line CDK 4/6 Inhibitors: Insights from the Randomized Phase II MAINTAIN Trial

Clinical Cancer Research·2025

Single Nuclei-Derived Molecular Subtypes of Gastrointestinal Stromal Tumors Correlate with Clinicopathologic Features and Predict Clinical Outcomes

2025Open Access

485 Comparative gene expression and mutational profiling of neuroendocrine tumors and neuroendocrine carcinomas in relation to clinical outcomes

1 cited

Journal of Clinical and Translational Science·2025· 1 citedOpen Access

Comparative outcomes of neuroendocrine tumors in the historically underserved population of Bronx, NY: Montefiore Einstein Comprehensive Cancer Center.

Journal of Clinical Oncology·2025

Supplementary Figures S1-S6 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies

2024Open Access

Table S2 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies

2024Open Access

Table S8 from A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies

2024Open Access

page 1 of 7Next →

Frequent Co-authors

Andrea Califano(24), Filemon S. Dela Cruz(19), Andrew L. Kung(19), Dawn L. Hershman(17), Katherine D. Crew(16), Melissa Accordino(15), Adina Grunn(15), Mariano J. Alvarez(14), Daniel Diolaiti(14), Hanina Hibshoosh(14), Kevin Kalinsky(13), Daoqi You(13), Charles Karan(13), Kristina Guillan(12), Armaan Siddiquee(12), Ronald Realubit(12), Michael V. Ortiz(12), Allison R. Rainey(12), Gulam A. Manji(11), Gary K. Schwartz(11)